Navigation Links
Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement
Date:2/12/2008

eutical products.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking terminology such as "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "plan," "potential," "predict," "should," or "will," or the negative thereof or other variations thereon or comparable terminology. Any statements in this press release regarding the acquisition, Cellegy's business and technology, and Adamis' business and technology that are not historical facts may be considered "forward-looking statements," including statements regarding the acquisition, its expected benefits, and the acquisition's anticipated timing. Cellegy has based these forward-looking statements on management's current preliminary expectations, assumptions, estimates and projections. While Cellegy believes its expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond its control. Such risks and uncertainties relate to, among other factors: the risk that the transaction may not be completed or that the closing of the transaction may be delayed; the risk of a material adverse event affecting Cellegy; and risks relating to our continued operations. You should also review our discussion of risk factors and other disclosures in Cellegy's Annual Report on Form 10-K for the year ended December 31, 2006 and other filings with the Securities and Exchange Commission. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Cellegy undertakes no obligation to update any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrenc
'/>"/>

SOURCE Cellegy Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer
2. Peregrine Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
3. Access Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
4. XTL Biopharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
5. Koronis Pharmaceuticals Appoints David Drajeske Director of Business Development
6. Onyx Pharmaceuticals to Present at BIO CEO & Investor Conference
7. Idenix Pharmaceuticals to Present at BIO CEO & Investor Conference
8. Meditrina Pharmaceuticals, Inc. Announces Exclusive Global License Agreement With AstraZeneca
9. Arena Pharmaceuticals to Present at the BIO CEO & Investor Conference
10. SGX Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... 2 Martek Biosciences Co... intends to release the results of its fourth quar...approximately 4:00 p.m. Eastern Time (ET). Follow...ct a conference call to discuss these results with...the call live via webcast by visiting Martek,s web...
(Date:12/2/2009)...Newswire-USNewswire/ -- Nearly 600 medical researc...rs today convened to explore novel development app...naugural Partnering for Cures meeting. ,, F...lken Institute, convened Partnering for Cures to...turn a scientific discovery into an accessible the...
(Date:12/2/2009)...therlands, December 2 Pepscan Hold...y focusing on protein mimicking,technology for the... that it,has appointed Wim E.M. Mol, Ph.D. as new ...e responsible for all of Pepscans corporate functi...tion of the company. He brings to,Pepscan more tha...
(Date:12/2/2009)..., Dec. 2 /PRNewswire-Asia/ -- Simcere Pharmaceutic... ), a leading pharmaceutical company,specializing ...f branded,generic and proprietary pharmaceuticals ...ve been included in China,s National Drug Reimburs...inistry of Human Resources and Social,Security on ...
Breaking Biology Technology:Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Dutch Biotech Company Pepscan Appoints New CEO 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3
...d for Targeting Tumors and Other, Abnormalities w...urgery, PALO ALTO, Calif., Sept. 18 Varian Medic...0(k) clearance for a new,high-definition multileaf...ce for radiosurgery. The new HD120 MLC multileaf ... precise radiosurgical treatments, including inten...
...cals Plc, a,private biopharmaceutical company focu...flammatory drugs, announced today that it has,appo...Chief Executive,Officer. Dr. Mazanet has significa...nagement in the biopharmaceutical industry. Dr. M... public,pharmaceutical companies. From June 1998 t...
...apies today,announced it has developed a novel ser... the treatment of female sexual dysfunction (FSD)....nt inhibitors designed to,regulate neuronal activi...elieves these compounds may have utility in the tr...), a condition that affects a significant,percenta...
Other Biology Technology:Varian Medical Systems Receives FDA 510(k) Clearance for High-Definition Collimator That Enables Ultra-Fine Intensity-Modulated Radiosurgery 2Varian Medical Systems Receives FDA 510(k) Clearance for High-Definition Collimator That Enables Ultra-Fine Intensity-Modulated Radiosurgery 3Morria Biopharmaceuticals Plc Announces Appointment of Dr. Rosemary Mazanet as Interim Chief Executive Officer 2Intra-Cellular Therapies Provides Overview of its Proprietary Portfolio of Compounds for the Treatment of Female Sexual Dysfunction (FSD) 2Intra-Cellular Therapies Provides Overview of its Proprietary Portfolio of Compounds for the Treatment of Female Sexual Dysfunction (FSD) 3
(Date:12/4/2009)... Leskovar, a Texas AgriLife Research plant physiol... Center in Uvalde, has been investigating ways to ...tion from the greenhouse to the field. , "This r...ossibly even the further profitability of some veg...ive plants that will establish well," Leskovar sai...
(Date:12/4/2009)...vailable in German . , A new study of the Max... to understand the positive effect of dietary rest...different organisms (fruit flies and mice) have sh...but with a potential negative side effect of dimin...s less frequently with a reduced litter size on a ...
(Date:12/3/2009)...earn new information and adapt to changes in our d...mories, appears to lie in the minute junctions whe...dy by NYU Langone Medicine Center researchers. The...l Nature . , The scientists, led by Wen-Biao G...roscience at NYU School of Medicine, discovered th...
Breaking Biology News(10 mins):Texas AgriLife researchers helping 2Texas AgriLife researchers helping 3Texas AgriLife researchers helping 4How nutrition affects healthy aging 2Lifelong memories linked to stable nerve connections 2Dr James OConnell Named J H Kanter Prize Laureate 54148 1Dr James OConnell Named J H Kanter Prize Laureate 54148 2Dr James OConnell Named J H Kanter Prize Laureate 54148 3Kevin Nealon Jordan Farmar Walter Perez Cristian de la Fuente and Other Celebrities Participated in Beach Volleyball Match for Children With Cancer 54145 1Kevin Nealon Jordan Farmar Walter Perez Cristian de la Fuente and Other Celebrities Participated in Beach Volleyball Match for Children With Cancer 54145 2Kevin Nealon Jordan Farmar Walter Perez Cristian de la Fuente and Other Celebrities Participated in Beach Volleyball Match for Children With Cancer 54145 3William Stanfield MD Is First Cleveland area Orthopedic Surgeon to Perform OtisKnee Custom Fit Knee Replacement 13481 1William Stanfield MD Is First Cleveland area Orthopedic Surgeon to Perform OtisKnee Custom Fit Knee Replacement 13481 2William Stanfield MD Is First Cleveland area Orthopedic Surgeon to Perform OtisKnee Custom Fit Knee Replacement 13481 3William Stanfield MD Is First Cleveland area Orthopedic Surgeon to Perform OtisKnee Custom Fit Knee Replacement 13481 4
...ne of the central challenges of our time is the su...ce-efficient energy to our society. In this contex...rtance. Bjrn Loges, Albert Boddien, Henrik Junge, ...talysis in Rostock have now succeeded in the contr...ut the need for the high-temperature reforming pro...
...ware, WALL, N.J., May 6 BIO-key International, I...-based biometric,identification and wireless publi...e showcasing its latest mobile data solution for B...forcement Information Management,(LEIM) Conference...t and,Convention Center in Nashville, TN., The LE...
...e exploited to make them more sensitive to heat an...School of Medicine in St. Louis report. , The Was...found that tumors have a built-in mechanism that p...ost likely decreases the benefit of hyperthermia a...ing with that protection, the researchers have sho...
Other Biology News:Power from formic acid 2BIO-key(R) Showcasing Public Safety Solutions for BlackBerry Smartphones at 2008 LEIM Conference 2BIO-key(R) Showcasing Public Safety Solutions for BlackBerry Smartphones at 2008 LEIM Conference 3Researchers find way to make tumor cells easier to destroy 2
... Clean-up Micro Kit provides a fast and simple pro...100 and other detergents from small samples of pro...sing Norgens patented protein resin as an ion exch... of either acidic or basic protein.A complete kit ...
...is critical to the maintenance of appropriate leve...tant and diverse as those involved in cellular met...resentation, modulation of cell surface receptors ...tion, and signalling factors. The ubiquitin-protea...
...ion Service includes 1. Scanning of gel(s) 2. Exci...yptic in-gel digestion and peptide extraction 4. P...of PMF (Peptide Mass Fingerprint) spectra via MALD...PFF (Peptide Fragmentation Fingerprint) spectra vi...
Yeast-GFP 96-well Plates from Invitrogen
Biology Products: